Engineered blood vessels could change heart surgery

NCT ID NCT07078370

ENROLLING_BY_INVITATION Disease control Sponsor: Vascudyne, Inc. Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 12, 2026 · Updated 20 times

Summary

This study tests a new lab-made blood vessel (ATEV) for coronary bypass surgery in 20 people with multi-vessel heart disease. The goal is to see if it is safe and works well when used alongside standard bypass grafts. Participants will be followed for up to 12 months to check for complications and whether the vessel stays open.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Medicover

    Warsaw, Poland

  • University Clinical Hospital No. 2 PUM in Szczecin

    Szczecin, Poland

Conditions

Explore the condition pages connected to this study.